Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

Background Defective cellular transport processes can lead to aberrant accumulation of trace elements, iron, small molecules and hormones in the cell, which in turn may promote the formation of reactive oxygen species, promoting DNA damage and aberrant expression of key regulatory cancer genes. As DNA damage and uncontrolled proliferation are hallmarks of cancer, including epithelial ovarian cancer (EOC), we hypothesized that inherited variation in the cellular transport genes contributes to EOC risk. Methods In total, DNA samples were obtained from 14,525 case subjects with invasive EOC and from 23,447 controls from 43 sites in the Ovarian Cancer Association Consortium (OCAC). Two hundred seventy nine SNPs, representing 131 genes, were genotyped using an Illumina Infinium iSelect BeadChip as part of the Collaborative Oncological Gene-environment Study (COGS). SNP analyses were conducted using unconditional logistic regression under a log-additive model, and the FDR q<0.2 was applied to adjust for multiple comparisons. Results The most significant evidence of an association for all invasive cancers combined and for the serous subtype was observed for SNP rs17216603 in the iron transporter gene HEPH (invasive: OR = 0.85, P = 0.00026; serous: OR = 0.81, P = 0.00020); this SNP was also associated with the borderline/low malignant potential (LMP) tumors (P = 0.021). Other genes significantly associated with EOC histological subtypes (p<0.05) included the UGT1A (endometrioid), SLC25A45 (mucinous), SLC39A11 (low malignant potential), and SERPINA7 (clear cell carcinoma). In addition, 1785 SNPs in six genes (HEPH, MGST1, SERPINA, SLC25A45, SLC39A11 and UGT1A) were imputed from the 1000 Genomes Project and examined for association with INV EOC in white-European subjects. The most significant imputed SNP was rs117729793 in SLC39A11 (per allele, OR = 2.55, 95% CI = 1.5-4.35, p = 5.66x10-4). Conclusion These results, generated on a large cohort of women, revealed associations between inherited cellular transport gene variants and risk of EOC histologic subtypes.

Yurii B. Shvetsov | A. Whittemore | L. Kiemeney | M. Pike | M. Beckmann | P. Fasching | R. Vierkant | T. Sellers | A. Hein | J. Chang-Claude | B. Fridley | E. Goode | B. Karlan | N. Le | A. Berchuck | E. Iversen | G. Giles | T. Dörk | M. Southey | D. Easton | Xifeng Wu | P. Pharoah | D. Lambrechts | A. Brooks-Wilson | D. Levine | Ya-Yu Tsai | L. Wilkens | P. Hillemanns | X. Shu | Yu-tang Gao | W. Zheng | A. Ziogas | H. Anton-Culver | R. Glasspool | U. Menon | A. Gentry-Maharaj | K. Aben | D. Eccles | L. Brinton | J. Lissowska | H. Nevanlinna | N. Bogdanova | R. Milne | S. Orsulic | J. Cunningham | M. Goodman | S. Kjaer | J. Dennis | E. Dicks | A. Rudolph | A. Ekici | A. Jakubowska | J. Lubiński | N. Antonenkova | K. Matsuo | A. Wu | S. Teo | J. Tyrer | U. Eilber | S. Wang-gohrke | C. Bunker | A. Monteiro | S. Gayther | D. Cramer | N. Wentzensen | H. Jim | B. Rosen | I. Vergote | R. Ness | Hui-Yi Lin | E. Amankwah | I. McNeish | S. Olson | H. Risch | L. Kelemen | S. Narod | K. Odunsi | I. Campbell | I. Runnebaum | I. Orlow | R. Weber | J. Doherty | J. Schildkraut | K. Moysich | F. Modugno | B. Ji | G. Chornokur | E. Schernhammer | K. Lu | M. Bisogna | J. McLaughlin | H. Salvesen | L. Massuger | L. Sucheston | Y. Woo | A. V. van Altena | E. Bandera | M. Hildebrandt | C. Pearce | F. Heitz | P. Harter | A. du Bois | R. Butzow | K. Lawrenson | Hannah P. Yang | J. Lester | C. Cybulski | V. McGuire | J. Rothstein | W. Sieh | C. Walsh | M. Rossing | Zhihua Chen | Honglin Song | C. Phelan | A. Jensen | L. Cook | J. Gronwald | N. Siddiqui | S. Tworoger | R. Edwards | C. Høgdall | S. Ramus | L. Bjørge | C. Krakstad | Xiaotao Qu | J. Permuth-Wey | P. Harrington | J. Paul | T. Pejović | I. Rzepecka | A. Dansonka-Mieszkowska | J. Kupryjańczyk | L. Thomsen | E. Despierre | L. Pelttari | K. Wicklund | P. Thompson | Ann Chen | F. Bruinsma | Yukie T. Bean | K. Carty | M. Dürst | E. Høgdall | S. Hosono | Mellissa Kellar | S. Lambrechts | Alice W. Lee | S. Lele | A. Leminen | Dong Liang | B. Lim | L. Lundvall | E. Poole | I. Schwaab | Y. Shvetsov | B. Śpiewankiewicz | K. Terry | I. L. Tangen | H. Hasmad | Lara E. Sucheston | Liisa M. Pelttari | Yu-Tang Gao | Ya‐Yu Tsai | T. Pejovic | K. Lu | R. P. Weber | A. Monteiro | J. Permuth‐Wey | Yu-Tang Gao | Jennifer Permuth‐Wey | Yu-Tang Gao | Maria Bisogna | K. Lu | J. Paul | A. van Altena | R. Edwards | A. Wu | J. McLaughlin

[1]  V. A. Flørenes,et al.  MGST1 expression in serous ovarian carcinoma differs at various anatomic sites, but is unrelated to chemoresistance or survival. , 2012, Gynecologic oncology.

[2]  荒牧 潤.  Polymorphism of UDP-glucuronosyltransferase 1A7 gene : a possible new risk factor for lung cancer , 2006 .

[3]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[4]  J. Lacki,et al.  A novel mutation (del 1711 G) in the TBG gene as a cause of complete TBG deficiency. , 2007, Thyroid : official journal of the American Thyroid Association.

[5]  Juxing Chen,et al.  Abnormal iron uptake and liver cancer , 2009, Cancer biology & therapy.

[6]  E. Nemeth.  Iron regulation and erythropoiesis , 2008, Current opinion in hematology.

[7]  C. Guillemette,et al.  Regulation of the UGT1A1 bilirubin‐conjugating pathway: Role of a new splicing event at the UGT1A locus , 2007, Hepatology.

[8]  M. Rubin,et al.  Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis. , 2001, Neoplasia.

[9]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[10]  J. Inazawa,et al.  HECT-type Ubiquitin Ligase ITCH Targets Lysosomal-associated Protein Multispanning Transmembrane 5 (LAPTM5) and Prevents LAPTM5-mediated Cell Death* , 2011, The Journal of Biological Chemistry.

[11]  D. Maeder,et al.  Profiling of zinc-altered gene expression in human prostate normal vs. cancer cells: a time course study. , 2009, The Journal of nutritional biochemistry.

[12]  Eva M. Schmelz,et al.  Metabolic changes during ovarian cancer progression as targets for sphingosine treatment. , 2013, Experimental cell research.

[13]  A. Whittemore,et al.  Histologic types of epithelial ovarian cancer: have they different risk factors? , 2005, Gynecologic oncology.

[14]  F. Schmitt,et al.  GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression. , 2011, Histology and histopathology.

[15]  R. Morgenstern,et al.  Microsomal glutathione transferase 1: mechanism and functional roles , 2011, Drug metabolism reviews.

[16]  V. Labhasetwar,et al.  Oh the irony: Iron as a cancer cause or cure? , 2011, Biomaterials.

[17]  H. Fuchs.  Iron metabolism and disease. , 2008 .

[18]  W. Chung,et al.  Molecular and functional analysis of SLC25A20 mutations causing carnitine‐acylcarnitine translocase deficiency , 2004, Human mutation.

[19]  K. Yeh,et al.  Interactions between ferroportin and hephaestin in rat enterocytes are reduced after iron ingestion. , 2011, Gastroenterology.

[20]  J. Gohagan,et al.  Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. , 2011, JAMA.

[21]  M. L. Genova,et al.  Mitochondrial respiratory chain super-complex I-III in physiology and pathology. , 2010, Biochimica et biophysica acta.

[22]  E. Halperin,et al.  Estimating Local Ancestry in Admixed Populations , 2022 .

[23]  Nicholas R. Lemoine,et al.  A practical guide for the functional annotation of genetic variations using SNPnexus , 2013, Briefings Bioinform..

[24]  R. Moorehead,et al.  Use of a transgenic mouse model to identify markers of human lung tumors , 2005, International journal of cancer.

[25]  T. Hampton,et al.  The Cancer Genome Atlas , 2020, Indian Journal of Medical and Paediatric Oncology.

[26]  F. Schmitt,et al.  396 GLUT1 and CAIX expression profiles in breast cancer correlate with MCT1 overexpression , 2010 .

[27]  M. Manns,et al.  UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer. , 2003, Gastroenterology.

[28]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[29]  I. Endo,et al.  Association between breast cancer risk and the wild-type allele of human ABC transporter ABCC11. , 2010, Anticancer research.

[30]  Diana B. Petitti,et al.  Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine , 1994 .

[31]  C. Vulpe,et al.  Functional studies of hephaestin in yeast: evidence for multicopper oxidase activity in the endocytic pathway. , 2003, The Biochemical journal.

[32]  Xi Huang.  Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal. , 2003, Mutation research.

[33]  R. Sinha,et al.  Iron Homeostasis and Distal Colorectal Adenoma Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial , 2011, Cancer Prevention Research.

[34]  Robert Fredriksson,et al.  Fourteen novel human members of mitochondrial solute carrier family 25 (SLC25) widely expressed in the central nervous system. , 2006, Genomics.

[35]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[36]  John D. Storey.  A direct approach to false discovery rates , 2002 .

[37]  K. Hashizume,et al.  Autosomally transmitted low concentration of thyroxine-binding globulin. , 1999, Thyroid : official journal of the American Thyroid Association.

[38]  C. Lehmann.  Oh, the Irony! , 2012 .

[39]  J. Best,et al.  Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer , 2005, Journal of cellular physiology.

[40]  D. Richardson,et al.  Novel chelators for cancer treatment: where are we now? , 2013, Antioxidants & redox signaling.

[41]  E. Gabazza,et al.  Polymorphism of UDP-glucuronosyltransferase 1A7 gene: a possible new risk factor for lung cancer. , 2005, European journal of cancer.

[42]  H. Sevestre,et al.  Evidence that TRPM7 is required for breast cancer cell proliferation. , 2009, American journal of physiology. Cell physiology.

[43]  S. Filetti,et al.  Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism. , 1999, European journal of endocrinology.

[44]  G. Berx,et al.  Modulation of iron transport proteins in human colorectal carcinogenesis , 2006, Gut.

[45]  L. Migliore,et al.  Mutation Research / Fundamental and Molecular Mechanisms of Mutagenesis , 2014 .

[46]  Dimitrios Galaris,et al.  Oxidative stress and iron homeostasis: mechanistic and health aspects. , 2008, Critical reviews in clinical laboratory sciences.

[47]  H. Risch,et al.  Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. , 1996, American journal of epidemiology.

[48]  Brooke L. Fridley,et al.  GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer , 2013, Nature Genetics.

[49]  G. Hortobagyi,et al.  Thyroid hormone and breast carcinoma , 2005, Cancer.

[50]  E. Feuer,et al.  Cancer survival among adults: US SEER Program, 1988-2001: patient and tumor characteristics. , 2007 .

[51]  Rudolfs K. Zalups,et al.  Cellular and Molecular Biology of Metals , 2010 .

[52]  F. Palmieri.  The mitochondrial transporter family SLC25: identification, properties and physiopathology. , 2013, Molecular aspects of medicine.

[53]  Gregory J. Anderson,et al.  Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse , 1999, Nature Genetics.

[54]  G. Colditz,et al.  The Functional UGT1A1 Promoter Polymorphism Decreases Endometrial Cancer Risk , 2004, Cancer Research.

[55]  D. Eide.  The SLC39 family of metal ion transporters , 2004, Pflügers Archiv.

[56]  J. Lubiński,et al.  Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients , 2005, European Journal of Clinical Pharmacology.

[57]  W. Sly,et al.  The iron gatekeeper: keys to the front and back doors , 2003 .

[58]  Ferdinando Palmieri,et al.  The mitochondrial transporter family (SLC25): physiological and pathological implications , 2004, Pflügers Archiv.

[59]  Jack A. Taylor,et al.  SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies , 2009, Nucleic Acids Res..

[60]  J. Marchini,et al.  Fast and accurate genotype imputation in genome-wide association studies through pre-phasing , 2012, Nature Genetics.

[61]  Ian O Ellis,et al.  The Emerging Role of the LIV-1 Subfamily of Zinc Transporters in Breast Cancer , 2007, Molecular medicine.

[62]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[63]  K. Fitzsimmons,et al.  Identification of High Affinity Binding Sites for Inhibin on Ovine Pituitary Cells in Culture* *This work was supported by consecutive program grants (Regkey 943208 and 983212) from the National Health and Medical Research Council of Australia. , 1999, Endocrinology.

[64]  M. Lung,et al.  Microsomal glutathione S-transferase gene polymorphisms and colorectal cancer risk in a Han Chinese population , 2007, International Journal of Colorectal Disease.

[65]  L. Frati,et al.  UDP-glucuronosyltransferases 1A expression in human urinary bladder and colon cancer by immunohistochemistry. , 2005, Oncology reports.

[66]  R. Tukey,et al.  Human UDP-glucuronosyltransferases: metabolism, expression, and disease. , 2000, Annual review of pharmacology and toxicology.

[67]  E. Amankwah,et al.  Global ovarian cancer health disparities. , 2013, Gynecologic oncology.

[68]  Mitsuaki Suzuki,et al.  Clinicopathological characteristics of mucinous adenocarcinoma of the ovary. , 2009, Gynecologic oncology.

[69]  J. Whisstock,et al.  An overview of the serpin superfamily , 2006, Genome Biology.

[70]  R. Reis,et al.  Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer , 2011, BMC Cancer.

[71]  R. Domingues,et al.  A novel variant in Serpina7 gene in a family with thyroxine-binding globulin deficiency , 2009, Endocrine.

[72]  A. Sood,et al.  Unmasking the complexities of mucinous ovarian carcinoma. , 2010, Gynecologic oncology.